-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery Equipment Network ] From the perspective of the development trend of the world's biomedical industry, it is currently at the beginning of the large-scale industrialization of biomedical technology.
However, the industry predicts that after 2020, the biomedical industry will enter a period of rapid development and will gradually become a leading industry for the world economy.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipmentHowever, the industry predicts that after 2020, the biomedical industry will enter a period of rapid development and will gradually become a leading industry for the world economy.
In my country, in recent years, driven by favorable policies, economic development, population aging and other social factors, as well as multiple factors such as biopharmaceutical technology, the influx of overseas capital, and the return of talents in large numbers, the biopharmaceutical industry has also developed to a considerable extent.
The scale continues to expand.
The industry predicts that China's biopharmaceuticals will maintain a compound annual growth rate of 16.
4% from 2016 to 2021, reaching a market size of 326.
9 billion yuan by 2021, and the market size may exceed 500 billion yuan by 2025.
The scale continues to expand.
The industry predicts that China's biopharmaceuticals will maintain a compound annual growth rate of 16.
4% from 2016 to 2021, reaching a market size of 326.
9 billion yuan by 2021, and the market size may exceed 500 billion yuan by 2025.
From the above, we can see that my country's biomedical industry has a bright future.
So, in this context, as the pharmaceutical equipment industry, which is closely related to the pharmaceutical industry, what kind of assistance will it provide for the development of the biopharmaceutical industry? It is understood that in the process of high-quality development of the biopharmaceutical industry, the requirements for downstream purification processes and equipment are getting higher and higher, especially for the structural parameters, process parameters, and control methods of biopharmaceutical equipment.
Requirements.
Pharmaceutical equipmentSo, in this context, as the pharmaceutical equipment industry, which is closely related to the pharmaceutical industry, what kind of assistance will it provide for the development of the biopharmaceutical industry? It is understood that in the process of high-quality development of the biopharmaceutical industry, the requirements for downstream purification processes and equipment are getting higher and higher, especially for the structural parameters, process parameters, and control methods of biopharmaceutical equipment.
Requirements.
Therefore, if pharmaceutical equipment companies want to help the development of the biopharmaceutical industry, they cannot do without two aspects.
One is to innovate equipment and optimize the technology of the equipment; the other is to seize the needs of users to create hygienic, efficient, economical, and convenient cost-effective equipment.
It is reported that in order to promote the better development of the biopharmaceutical industry, domestic biopharmaceutical equipment manufacturers have begun to provide biopharmaceutical companies with many powerful equipment, accessories and technical support through continuous efforts to strengthen innovation and research and development.
One is to innovate equipment and optimize the technology of the equipment; the other is to seize the needs of users to create hygienic, efficient, economical, and convenient cost-effective equipment.
It is reported that in order to promote the better development of the biopharmaceutical industry, domestic biopharmaceutical equipment manufacturers have begun to provide biopharmaceutical companies with many powerful equipment, accessories and technical support through continuous efforts to strengthen innovation and research and development.
For example, in order to meet the needs of pharmaceutical companies, some companies have further broadened their product lines, launched targeted biopharmaceutical equipment, and formed orders.
At the same time, some companies rely on their accumulated high-level cold work technology, polishing technology, engineering design and installation technology to develop and produce a series of biological fermentation tanks , stainless steel tanks, laboratory reactors, electric heating reactors and other products.
Fermenter At the same time, some companies rely on their accumulated high-level cold work technology, polishing technology, engineering design and installation technology to develop and produce a series of biological fermentation tanks , stainless steel tanks, laboratory reactors, electric heating reactors and other products.
There are also pharmaceutical equipment companies, which customized a set of 500L fermentation equipment for genetic recombination and protein drug production according to customer needs.
This set of equipment is mainly composed of three parts: tank, piping system and control system.
Both in terms of product performance and product structure, they are tailor-made in accordance with high-standard GMP standards.
The manufacturing level of tanks is also in an advantageous position among domestic and foreign counterparts.
It is understood that because of this fermentation equipment, the company has also gained many customers in the fields of genetic recombination and protein drug production in the past two years.
And at the 2020 Shanghai Biological Fermentation Exhibition, we have received very good market feedback.
This set of equipment is mainly composed of three parts: tank, piping system and control system.
Both in terms of product performance and product structure, they are tailor-made in accordance with high-standard GMP standards.
The manufacturing level of tanks is also in an advantageous position among domestic and foreign counterparts.
It is understood that because of this fermentation equipment, the company has also gained many customers in the fields of genetic recombination and protein drug production in the past two years.
And at the 2020 Shanghai Biological Fermentation Exhibition, we have received very good market feedback.
In addition, some companies actively embrace the intelligent manufacturing of biopharmaceuticals according to the "Made in China 2025" plan, are committed to promoting the continuous production and intelligent manufacturing of biopharmaceuticals, and innovatively develop key biopharmaceutical equipment (bioreactors, bioengineering liquid dosing modules) And intelligent production platform (Bio-PAS), etc.
In general, domestic pharmaceutical equipment companies are accelerating innovative research and development in order to meet the development needs of biomedicine.
However, it should be noted that the equipment used in the domestic biopharmaceutical industry is almost entirely dependent on imports.
Therefore, in the future, domestic pharmaceutical equipment companies will need to continuously improve their core technologies to further improve the quality of domestic biological equipment.
After breaking the technological monopoly, speed up the substitution of imported products.
However, it should be noted that the equipment used in the domestic biopharmaceutical industry is almost entirely dependent on imports.
Therefore, in the future, domestic pharmaceutical equipment companies will need to continuously improve their core technologies to further improve the quality of domestic biological equipment.
After breaking the technological monopoly, speed up the substitution of imported products.
Original title: The biomedical industry is booming, are pharmaceutical companies ready to meet the opportunity?
